Fabiola Dell'acqua

Monza, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

The novel XIAP Lys396Ter variant alters mitochondrial membrane potential and endoplasmic reticulum intensity in monocytes of two XIAP-deficient patients.

The novel XIAP Lys396Ter variant alters mitochondrial membrane potential and endoplasmic reticulum intensity in monocytes of two XIAP-deficient patients.

Journal: Pediatric hematology and oncology

Published: June 25, 2025

Neurodegeneration in patients with multisystem Langerhans cell histiocytosis treated with vemurafenib.

Neurodegeneration in patients with multisystem Langerhans cell histiocytosis treated with vemurafenib.

Journal: British journal of haematology

Published: February 01, 2024

Outcome of primary hemophagocytic lymphohistiocytosis: a report on 143 patients from the Italian Registry.

Outcome of primary hemophagocytic lymphohistiocytosis: a report on 143 patients from the Italian Registry.

Journal: Haematologica

Published: July 19, 2023

Pediatric immune myelofibrosis (PedIMF) as a novel and distinct clinical pathological entity.

Pediatric immune myelofibrosis (PedIMF) as a novel and distinct clinical pathological entity.

Journal: Frontiers in pediatrics

Published: August 30, 2022

Near-tetraploid T-cell acute lymphoblastic leukaemia in childhood: Results of the AIEOP-BFM ALL studies.

Near-tetraploid T-cell acute lymphoblastic leukaemia in childhood: Results of the AIEOP-BFM ALL studies.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 19, 2022

Mucopolysaccharidosis-Plus Syndrome, a Rapidly Progressive Disease: Favorable Impact of a Very Prolonged Steroid Treatment on the Clinical Course in a Child.

Mucopolysaccharidosis-Plus Syndrome, a Rapidly Progressive Disease: Favorable Impact of a Very Prolonged Steroid Treatment on the Clinical Course in a Child.

Journal: Genes

Published: February 08, 2022

Pharmacological and clinical monitoring in children with acute lymphoblastic leukemia treated with a biogeneric PEG-l-asparaginase product.

Pharmacological and clinical monitoring in children with acute lymphoblastic leukemia treated with a biogeneric PEG-l-asparaginase product.

Journal: Pediatric blood & cancer

Published: December 27, 2021

Hermansky-Pudlak syndrome type II and lethal hemophagocytic lymphohistiocytosis: Case description and review of the literature.

Hermansky-Pudlak syndrome type II and lethal hemophagocytic lymphohistiocytosis: Case description and review of the literature.

Journal: The journal of allergy and clinical immunology. In practice

Published: March 01, 2019

Williams syndrome and mature B-Leukemia: A random association?

Williams syndrome and mature B-Leukemia: A random association?

Journal: European journal of medical genetics

Published: October 11, 2016

Asparagine levels in the bone marrow of patients with acute lymphoblastic leukemia during asparaginase therapy.

Asparagine levels in the bone marrow of patients with acute lymphoblastic leukemia during asparaginase therapy.

Journal: Pediatric blood & cancer

Published: May 01, 2013

Incidence, clinical features and management of hypersensitivity reactions to chemotherapeutic drugs in children with cancer.

Incidence, clinical features and management of hypersensitivity reactions to chemotherapeutic drugs in children with cancer.

Journal: European journal of clinical pharmacology

Published: March 07, 2013

Showing 1-11 of 11

Last Updated: 09/26/2026